GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ICARES Medicus Inc (ROCO:6612) » Definitions » Enterprise Value

ICARES Medicus (ROCO:6612) Enterprise Value : NT$4,964.3 Mil (As of Apr. 27, 2025)


View and export this data going back to 2016. Start your Free Trial

What is ICARES Medicus Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ICARES Medicus's Enterprise Value is NT$4,964.3 Mil. ICARES Medicus's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was NT$182.7 Mil. Therefore, ICARES Medicus's EV-to-EBIT ratio for today is 27.17.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, ICARES Medicus's Enterprise Value is NT$4,964.3 Mil. ICARES Medicus's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was NT$271.8 Mil. Therefore, ICARES Medicus's EV-to-EBITDA ratio for today is 18.27.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, ICARES Medicus's Enterprise Value is NT$4,964.3 Mil. ICARES Medicus's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was NT$859.8 Mil. Therefore, ICARES Medicus's EV-to-Revenue ratio for today is 5.77.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, ICARES Medicus's Enterprise Value is NT$4,964.3 Mil. ICARES Medicus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-167.5 Mil. Therefore, ICARES Medicus's EV-to-FCF ratio for today is -29.63.


ICARES Medicus Enterprise Value Historical Data

The historical data trend for ICARES Medicus's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ICARES Medicus Enterprise Value Chart

ICARES Medicus Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,880.02 2,055.16 2,412.43 4,178.25 5,588.89

ICARES Medicus Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,178.25 3,597.36 6,234.65 6,817.47 5,588.89

Competitive Comparison of ICARES Medicus's Enterprise Value

For the Medical Instruments & Supplies subindustry, ICARES Medicus's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ICARES Medicus's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ICARES Medicus's Enterprise Value distribution charts can be found below:

* The bar in red indicates where ICARES Medicus's Enterprise Value falls into.


;
;

ICARES Medicus Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

ICARES Medicus's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

ICARES Medicus's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ICARES Medicus  (ROCO:6612) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

ICARES Medicus's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4964.287/182.733
=27.17

ICARES Medicus's current Enterprise Value is NT$4,964.3 Mil.
ICARES Medicus's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$182.7 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

ICARES Medicus's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=4964.287/271.777
=18.27

ICARES Medicus's current Enterprise Value is NT$4,964.3 Mil.
ICARES Medicus's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$271.8 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

ICARES Medicus's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4964.287/859.793
=5.77

ICARES Medicus's current Enterprise Value is NT$4,964.3 Mil.
ICARES Medicus's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$859.8 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

ICARES Medicus's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4964.287/-167.544
=-29.63

ICARES Medicus's current Enterprise Value is NT$4,964.3 Mil.
ICARES Medicus's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-167.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ICARES Medicus Enterprise Value Related Terms

Thank you for viewing the detailed overview of ICARES Medicus's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ICARES Medicus Business Description

Traded in Other Exchanges
N/A
Address
Number 16, Sec.2, Sheng Yi Road, 4th Floor, Hsinchu County, Zhubei, TWN, 30261
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices and designing, developing, manufacturing and sale of intraocular lenses and nanomedical devices. Its products include Artificial Lens. The Company manages segments based on geography, and divides segments into the R.O.C segment, the China segment, and the U.S.A segment. It earns the majority of its revenue from U.S.A. segment.

ICARES Medicus Headlines

No Headlines